Careprost plus applicators is a prescription ophthalmic solution containing bimatoprost that is supplied with a single-use brush applicator for applying the medication to the upper eyelid margin. The primary therapeutic purpose of the product is to promote the growth of longer thicker and darker eyelashes in individuals with inadequate natural lash volume. Bimatoprost is a synthetic prostaglandin analog that mimics the action of naturally occurring prostaglandin f2a receptors in the ciliary body and iris. When applied to the lash line the drug penetrates the superficial skin layers and reaches the hair follicle microenvironment where it binds to prostaglandin receptors associated with the anagen phase of the lash growth cycle. Activation of these receptors stimulates proliferation of eyelash hair matrix cells and prolongs the anagen phase leading to increased follicular activity. The sustained activation also enhances melanin production in the lash shaft resulting in darker pigmentation of the newly formed lashes. Systemic absorption is minimal because the formulation is applied locally to a low-vascularized area and the amount of drug reaching the bloodstream is insufficient to cause systemic effects. The combination of direct topical delivery and targeted receptor activation enables the medication to achieve its cosmetic effect without requiring oral administration or invasive procedures.

Careprost contains bimatoprost which is a synthetic prostaglandin analog. It is formulated to treat insufficient eyelash growth and to lower intraocular pressure. The drug binds to prostaglandin fp receptors on the eyelash follicle and in the eye drainage system. Activation of these receptors prolongs the growth phase of lashes and increases fluid outflow from the eye. This dual action explains its cosmetic and therapeutic effects. The topical applicators deliver the solution precisely to the lash line for consistent absorption. Pharmacodynamically the medication enhances lash length thickness and pigmentation through receptor mediated hair cycle modulation. Pharmacokinetically the compound is absorbed locally with minimal systemic exposure and together these properties define the medication's mechanism of action.

When applied to the eyelids careprost with its applicator may cause mild redness. Some users experience temporary itching or a sensation of dryness near the treated area. Occasional swelling of the eye surface can occur but usually resolves quickly. A few people notice slight darkening of the skin around the lash line. Mild discomfort during the first few applications is also reported. These effects are generally short lived and do not require medical intervention unless they persist.

Eye irritation may occur after applying careprost with the applicator. Mild itching of the ocular area can be experienced. Dryness of the eyelid skin is sometimes reported. Transient redness around the eye may appear. Occasional blurring of vision may happen shortly after use. Localized skin darkening of the eyelid can develop with repeated application. Allergic reactions such as swelling or rash may occasionally be observed.